PubMed

Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule.

Vergouwe Y, Soedamah-Muthu SS, Zgibor J, Chaturvedi N, Forsblom C, Snell-Bergeon JK, Maahs DM, Groop PH, Rewers M, Orchard TJ, Fuller JH, Moons KG.

Diabetologia. 2009 Nov 4. [Epub ahead of print]PMID: 19908023 [PubMed - as supplied by publisher]Related articles

Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.

Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetes Care. 2009 Oct;32(10):1896-900. Epub 2009 Jul 8.PMID: 19587366 [PubMed - in process]Related articles

ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study.

Gruden G, Bruno G, Chaturvedi N, Burt D, Pinach S, Schalkwijk C, Stehouwer CD, Witte DR, Fuller JH, Cavallo-Perin P; EURODIAB Prospective Complications Study Group.

J Intern Med. 2009 May 8. [Epub ahead of print]PMID: 19563392 [PubMed - as supplied by publisher]Related articles

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH; CARDS Investigators.

Am J Kidney Dis. 2009 Nov;54(5):810-9. Epub 2009 Jun 21.PMID: 19540640 [PubMed - indexed for MEDLINE]Related articles

Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study.

Burt D, Bruno G, Chaturvedi N, Schalkwijk C, Stehouwer CD, Witte DR, Fuller JH, Pinach S, Perin PC, Gruden G.

Diabetes Care. 2009 Jul;32(7):1269-71. Epub 2009 Apr 14.PMID: 19366969 [PubMed - indexed for MEDLINE]Related articlesFree article

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.

Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Diabetologia. 2009 Apr;52(4):705-14. Epub 2009 Jan 30.PMID: 19183936 [PubMed - indexed for MEDLINE]Related articles

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

Newman CB, Szarek M, Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Demicco DA, Auster S, Fuller JH; Cards Investigators.

Diab Vasc Dis Res. 2008 Sep;5(3):177-83.PMID: 18777490 [PubMed - indexed for MEDLINE]Related articles

Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study.

Beulens JW, Kruidhof JS, Grobbee DE, Chaturvedi N, Fuller JH, Soedamah-Muthu SS.

Diabetologia. 2008 Sep;51(9):1631-8. Epub 2008 Jul 15.PMID: 18626626 [PubMed - indexed for MEDLINE]Related articles

Small-molecule microarrays as tools in ligand discovery.

Vegas AJ, Fuller JH, Koehler AN.

Chem Soc Rev. 2008 Jul;37(7):1385-94. Epub 2008 May 20. Review.PMID: 18568164 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy.

Gruden G, Bruno G, Chaturvedi N, Burt D, Schalkwijk C, Pinach S, Stehouwer CD, Witte DR, Fuller JH, Perin PC; EURODIAB Prospective Complications Study Group.

Diabetes. 2008 Jul;57(7):1966-70. Epub 2008 Apr 4.PMID: 18390793 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetes Care. 2008 Jul;31(7):1360-6. Epub 2008 Mar 28.PMID: 18375412 [PubMed - indexed for MEDLINE]Related articlesFree article

Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects.

Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, Curtis MA.

J Periodontal Res. 2008 Feb;43(1):103-10.PMID: 18230111 [PubMed - indexed for MEDLINE]Related articles

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).

Soedamah-Muthu SS, Chaturvedi N, Pickup JC, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetologia. 2008 Mar;51(3):493-501. Epub 2008 Jan 9.PMID: 18183363 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study.

Giunti S, Bruno G, Lillaz E, Gruden G, Lolli V, Chaturvedi N, Fuller JH, Veglio M, Cavallo-Perin P; EURODIAB IDDM Complications Study Group.

Diabetes Care. 2007 Aug;30(8):2057-63. Epub 2007 May 7.PMID: 17485572 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).

Raikou M, McGuire A, Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, Fuller JH; CARDS Investigators.

Diabetologia. 2007 Apr;50(4):733-40. Epub 2007 Jan 31.PMID: 17265034 [PubMed - indexed for MEDLINE]Related articles

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).

Neil HA, DeMicco DA, Luo D, Betteridge DJ, Colhoun HM, Durrington PN, Livingstone SJ, Fuller JH, Hitman GA; CARDS Study Investigators.

Diabetes Care. 2006 Nov;29(11):2378-84.PMID: 17065671 [PubMed - indexed for MEDLINE]Related articlesFree article

Weight gain is associated with improved glycaemic control but with adverse changes in plasma lipids and blood pressure isn Type 1 diabetes.

Ferriss JB, Webb D, Chaturvedi N, Fuller JH, Idzior-Walus B; EURODIAB Prospective Complications Group.

Diabet Med. 2006 May;23(5):557-64.PMID: 16681565 [PubMed - indexed for MEDLINE]Related articles

Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients.

Soedamah-Muthu SS, Chaturvedi N, Schalkwijk CG, Stehouwer CD, Ebeling P, Fuller JH; EURODIAB Prospective Complications Study group.

J Diabetes Complications. 2006 May-Jun;20(3):188-95.PMID: 16632240 [PubMed - indexed for MEDLINE]Related articles

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.

Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM.

Diabetes Care. 2006 Apr;29(4):798-804.PMID: 16567818 [PubMed - indexed for MEDLINE]Related articlesFree article

All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999.

Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM.

Diabetologia. 2006 Apr;49(4):660-6. Epub 2006 Jan 24.PMID: 16432708 [PubMed - indexed for MEDLINE]Related articles

Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study.

Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG.

Diabetes Care. 2006 Jan;29(1):26-31.PMID: 16373891 [PubMed - indexed for MEDLINE]Related articlesFree article

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Fuller JH; CARDS Investigators.

Diabetologia. 2005 Dec;48(12):2482-5. Epub 2005 Nov 12.PMID: 16284747 [PubMed - indexed for MEDLINE]Related articles

Is pregnancy a risk factor for microvascular complications? The EURODIAB Prospective Complications Study.

Vérier-Mine O, Chaturvedi N, Webb D, Fuller JH.

Diabet Med. 2005 Nov;22(11):1503-9.PMID: 16241914 [PubMed - indexed for MEDLINE]Related articles

Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.

Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD; Eurodiab ProspectivE Complications Study Group.

J Intern Med. 2005 Nov;258(5):450-9.PMID: 16238681 [PubMed - indexed for MEDLINE]Related articles

Adiponectin is inversely associated with renal function in type 1 diabetic patients.

Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

J Clin Endocrinol Metab. 2006 Jan;91(1):129-35. Epub 2005 Oct 11.PMID: 16219717 [PubMed - indexed for MEDLINE]Related articlesFree article

Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study.

Giunti S, Bruno G, Veglio M, Gruden G, Webb DJ, Livingstone S, Chaturvedi N, Fuller JH, Perin PC; Eurodiab IDDM Complications Study.

Diabetes Care. 2005 Sep;28(9):2255-7. No abstract available. PMID: 16123503 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study.

van Hecke MV, Dekker JM, Stehouwer CD, Polak BC, Fuller JH, Sjolie AK, Kofinis A, Rottiers R, Porta M, Chaturvedi N; EURODIAB prospective complications study.

Diabetes Care. 2005 Jun;28(6):1383-9.PMID: 15920056 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.

Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Hypertension. 2005 Jul;46(1):232-7. Epub 2005 Apr 25.PMID: 15851628 [PubMed - indexed for MEDLINE]Related articlesFree article

Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Diabetologia. 2005 Feb;48(2):370-8. Epub 2005 Feb 4.PMID: 15692810 [PubMed - indexed for MEDLINE]Related articles

Vascular risk factors and diabetic neuropathy.

Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH; EURODIAB Prospective Complications Study Group.

N Engl J Med. 2005 Jan 27;352(4):341-50.PMID: 15673800 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus.

Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetologia. 2005 Jan;48(1):164-71. Epub 2004 Dec 24.PMID: 15619072 [PubMed - indexed for MEDLINE]Related articles

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators.

Lancet. 2004 Aug 21-27;364(9435):685-96.PMID: 15325833 [PubMed - indexed for MEDLINE]Related articles

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.

Thomason MJ, Colhoun HM, Livingstone SJ, Mackness MI, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Fuller JH; CARDS Investigators.

Diabet Med. 2004 Aug;21(8):901-5.PMID: 15270795 [PubMed - indexed for MEDLINE]Related articles

Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.

Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetes Care. 2004 Feb;27(2):530-7.PMID: 14747240 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study.

Schram MT, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

J Hypertens. 2003 Nov;21(11):2035-44.PMID: 14597846 [PubMed - indexed for MEDLINE]Related articles

Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.

Chan NN, Fuller JH, Rubens M, Colhoun HM.

Med Sci Monit. 2003 Jul;9(7):CR297-303.PMID: 12883448 [PubMed - indexed for MEDLINE]Related articles

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study.

Diabetes Care. 2003 Jul;26(7):2165-73.PMID: 12832330 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.

Soedamah-Muthu SS, Colhoun HM, Thomason MJ, Betteridge DJ, Durrington PN, Hitman GA, Fuller JH, Julier K, Mackness MI, Neil HA; CARDS Investigators.

Atherosclerosis. 2003 Apr;167(2):243-55.PMID: 12818407 [PubMed - indexed for MEDLINE]Related articles

beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.

Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ.

Cancer Res. 2003 Jun 15;63(12):3145-53.PMID: 12810642 [PubMed - indexed for MEDLINE]Related articlesFree article

When medical students go off the rails. Lack of continuity from admission to postgraduate career is a problem.

Fuller JH.

BMJ. 2002 Dec 7;325(7376):1364. No abstract available. PMID: 12468496 [PubMed - indexed for MEDLINE]Related articlesFree article

Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study.

Chaturvedi N, Schalkwijk CG, Abrahamian H, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Diabetes Care. 2002 Dec;25(12):2320-7.PMID: 12453980 [PubMed - indexed for MEDLINE]Related articlesFree article

Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study.

Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerényi Z, Tamás G, Ward JD, Fuller JH; EURODIAB IDDM Complications Study Group.

Diabet Med. 2002 Nov;19(11):900-9.PMID: 12421426 [PubMed - indexed for MEDLINE]Related articles

Trends in hypertension management in Type I diabetes across Europe, 1989/1990 - 1997/1999.

Soedamah-Muthu SS, Colhoun HM, Abrahamian H, Chan NN, Mangili R, Reboldi GP, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetologia. 2002 Oct;45(10):1362-71. Epub 2002 Sep 7. Erratum in: Diabetologia. 2003 Nov;46(11):1589. PMID: 12378376 [PubMed - indexed for MEDLINE]Related articles

Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects.

Colhoun HM, Zito F, Norman Chan N, Rubens MB, Fuller JH, Humphries SE.

Atherosclerosis. 2002 Aug;163(2):363-9.PMID: 12052484 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH.

Diabetes. 2002 Jun;51(6):1949-56.PMID: 12031985 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia : the EURODIAB IDDM Complications Study Group.

Veglio M, Giunti S, Stevens LK, Fuller JH, Perin PC; EURODIAB IDDM Complications Study Group.

Diabetes Care. 2002 Apr;25(4):702-7.PMID: 11919128 [PubMed - indexed for MEDLINE]Related articlesFree article

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.

Colhoun HM, Thomason MJ, Mackness MI, Maton SM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Fuller JH; Collaborative AtoRvastatin Diabetes Study (CARDS).

Diabet Med. 2002 Mar;19(3):201-11.PMID: 11918622 [PubMed - indexed for MEDLINE]Related articles

Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications Study.

Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerényi Z, Tamás G, Ward JD, Fuller JH.

Arch Physiol Biochem. 2001 Jul;109(3):215-22.PMID: 11880924 [PubMed - indexed for MEDLINE]Related articles

Ethnicity and risk of diabetes-related lower extremity amputation: a population-based, case-control study of African Caribbeans and Europeans in the United kingdom.

Leggetter S, Chaturvedi N, Fuller JH, Edmonds ME.

Arch Intern Med. 2002 Jan 14;162(1):73-8.PMID: 11784222 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study.

Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetologia. 2001 Dec;44(12):2203-9.PMID: 11793022 [PubMed - indexed for MEDLINE]Related articles